Your browser doesn't support javascript.
Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?
Falchetti, A; Mohseni, M; Tramontana, F; Napoli, N.
  • Falchetti A; Unit of Bone and Mineral Metabolic Diseases, San Giuseppe Hospital, Piancavallo, Italy.
  • Mohseni M; Unit for Bone Metabolism Diseases and Diabetes and Lab of Endocrine and Metabolic Research, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
  • Tramontana F; Division of Bone and Mineral Diseases, Washington University in St Louis, St Louis, USA.
  • Napoli N; Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Via Alvaro del Portillo, 21, 00128, Rome, Italy.
J Endocrinol Invest ; 44(11): 2521-2524, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1188223
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Osteoporosis / Preventive Health Services / Quality of Life / Risk Adjustment / Osteoporotic Fractures / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Long Covid Limits: Aged / Female / Humans / Male Language: English Journal: J Endocrinol Invest Year: 2021 Document Type: Article Affiliation country: S40618-021-01552-1

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Osteoporosis / Preventive Health Services / Quality of Life / Risk Adjustment / Osteoporotic Fractures / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Long Covid Limits: Aged / Female / Humans / Male Language: English Journal: J Endocrinol Invest Year: 2021 Document Type: Article Affiliation country: S40618-021-01552-1